Viewing Study NCT05829434


Ignite Creation Date: 2025-12-25 @ 2:38 AM
Ignite Modification Date: 2026-02-20 @ 12:33 PM
Study NCT ID: NCT05829434
Status: WITHDRAWN
Last Update Posted: 2024-02-12
First Post: 2023-03-22
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Magrolimab Plus Intensive Chemotherapy in Newly Diagnosed AML or HR-MDS
Sponsor: Uwe Platzbecker
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myeloid Leukemia View
None Myelodysplastic Neoplasm View
Keywords:

Keywords

Keyword Brief Keyword Text View
None AML View
None Hihg-risk MDS View